MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysautonomia(see autonomic dysfunction)"

  • 2023 International Congress

    Serotonin Coma: An Antipodal emergency

    K C. Chudasama, V J. Jhala (Rajkot, India)

    Objective: To highlight the severity of Serotonin syndrome precipitated in a Psychiatric patient on two unique serotonergic medications leading to a comatose state. Background: Serotonin…
  • 2023 International Congress

    Cardiovascular autonomic function in GBA-associated Parkinson’s disease: a cross-sectional study

    T. de Santis, A. Cocco, P. Polverino, V. Polvere, EM. Valente, A. Albanese (Rozzano, Italy)

    Objective: To objectively assess cardiovascular autonomic function in patients with Parkinson’s disease (PD) carrying pathogenic variants of beta-glucocerebrosidase gene (GBA-PD) and compare to non-mutated PD…
  • 2022 International Congress

    Heart-brain synchronization breakdown in Parkinson’s disease

    M. Iniguez, A. Jimenez-Marin, A. Erramuzpe, M. Acera, B. Tijero, A. Murueta-Goyena, R. Del Pino, T. Fernandez, M. Carmona‑abellan, A. Cabrera, JC. Gomez‑esteban, J. Cortes, I. Gabilondo (Getafe, Spain)

    Objective: To evaluate the alterations in the synchronization between central autonomic network (CAN) activity and a broad set of heart rate variability (HRV) parameters reflecting…
  • 2022 International Congress

    Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

    C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)

    Objective: We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson’s disease (PD), defined as individuals providing regular…
  • 2022 International Congress

    Effect of levodopa-carbidopa intestinal gel on lower urinary tract symptoms in Parkinson’s disease: an Urodynamic study

    D. Rinaldi, O. Voglino, A. Tubaro, FE. Pontieri (rome, Italy)

    Objective: Here we report urodynamic results before and six months after LCIG treatment in PD patients suffering from LUTS. Background: Dopaminergic transmission plays a key…
  • 2022 International Congress

    Intermediate cardiac denervation in early Parkinson’s disease

    S-W. Yoo, J-S. Kim (Seoul, Republic of Korea)

    Objective: This study is aimed to evaluate the longitudinal associations between cardiac sympathetic denervation and cognitive status in Parkinson’s disease (PD). Background: There lacks an…
  • 2022 International Congress

    Nocturnal Polyuria in Parkinson’s Disease

    M. Smith, G. Portlock, A. Cullen, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To characterise the prevalence of nocturnal polyuria in a cohort of people with Parkinson’s disease (PD) with lower urinary tract symptoms. Background: Lower urinary…
  • MDS Virtual Congress 2021

    Paradoxical cerebral hyperperfusion in Parkinson’s disease with orthostatic hypotension

    S-W. Yoo, J-S. Kim, K-S. Lee, S. Ha (Seoul, Republic of Korea)

    Objective: This study manipulated the imaging modality to illustrate the physiology of cerebral flow with OH in PD (PD+OH). Background: Orthostatic hypotension (OH) may antedate…
  • MDS Virtual Congress 2020

    Cardiac Dysautonomia in Parkinson’s Disease

    A. Carwin, S. Miri, S. Nakano, M. Anjum, E. Mundel, J. Starr, C. Marsh, B. Wilmarth, M. Arellano, H. Howard, M. Hebron, Y. Torres-Yaghi, C. Moussa, F. Pagan (Washington, DC, USA)

    Objective: The aim of this study is to perform a preliminary investigation of the prevalence of cardiac autonomic dysfunction in newly diagnosed Parkinson’s patients. We…
  • MDS Virtual Congress 2020

    RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients

    G.M Riboldi, L. Pan, K. dePaiva Lopes, K. Watkins, T. Raj, U. Kang (New York, NY, USA)

    Objective: To determine whether newly diagnosed Parkinson’s disease (PD) patients with REM sleep behavior disorder (RBD) are more likely to have symptoms of autonomic dysfunction.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley